Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 24 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

42%

10 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

8 recruiting

Enrollment Performance

Analytics

Phase 2
7(35.0%)
Phase 3
6(30.0%)
Phase 4
4(20.0%)
N/A
3(15.0%)
20Total
Phase 2(7)
Phase 3(6)
Phase 4(4)
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT07568639Not ApplicableNot Yet Recruiting

Multi-Site Cortical Puncture for DOR

Role: collaborator

NCT07539792Phase 2Recruiting

Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in Extended Endoscopic Endonasal Transsphenoidal Surgery: A Prospective, Randomized, Controlled Study

Role: collaborator

NCT07459296Phase 3Recruiting

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Role: collaborator

NCT06265051Phase 2Completed

Tirofiban After Successful MT Recanalization in AIS

Role: collaborator

NCT07303283Phase 2Not Yet Recruiting

Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma

Role: collaborator

NCT07308600Not Yet Recruiting

Integrating Plasma Metagenomics and Host Response for Accurate Diagnosis of Infected Pancreatic Necrosis in a Prospective Multicenter Cohort of Acute Necrotizing Pancreatitis

Role: collaborator

NCT07312656Phase 2Not Yet Recruiting

Aerosolized Mesenchymal Stem Cell-Derived Exosomes for the Prevention and Treatment of Radiation-Induced Oral Mucositis

Role: collaborator

NCT06576024Phase 4Completed

Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People

Role: lead

NCT05340270Phase 2Active Not Recruiting

PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Role: collaborator

NCT07152639Phase 3Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above

Role: collaborator

NCT05780372Phase 3Recruiting

Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

Role: collaborator

NCT06763666Phase 4Not Yet Recruiting

CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML

Role: collaborator

NCT06728839Not ApplicableNot Yet Recruiting

Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Colonoscopy Cleansing

Role: collaborator

NCT04009525Phase 4Completed

Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study

Role: collaborator

NCT03895593Recruiting

Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections

Role: collaborator

NCT05717790Not ApplicableRecruiting

Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

Role: collaborator

NCT05682131Phase 4Recruiting

South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol

Role: collaborator

NCT05605145Unknown

PCP in Immunocompromised Population in Southern China

Role: collaborator

NCT03603977Recruiting

Simplified Treatment of Anti-retrovirus in China (C-STAR)

Role: collaborator

NCT04447326Phase 2Not Yet Recruiting

Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma

Role: collaborator